Financials
- Market Capitalization 208.63 M
- Employee 81
- Founded 1999
- CEO N/A
- Website www.agenusbio.com
- Headquarter Delaware, United States
- FIGI BBG000C8SWQ9
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
1.63
ratio cours/chiffre d'affaires
0.86
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3601 | RNA Atrium Therapeutics, Inc. - Common Stock | 12.32 USD | +0.82% | -7.85% | -3.37% | -82.48% | 210.74 M USD | ||
| 3618 | IMUX Immunic, Inc. - Common Stock | 15.00 USD | +2.11% | +1.56% | +6.16% | +1685.71% | 204.32 M USD | ||
| 3628 | CLLS Cellectis S.A. - American Depositary Shares | 2.81 USD | -2.43% | -9.65% | -10.79% | +42.64% | 201.62 M USD | ||
| 3633 | NERV Minerva Neurosciences, Inc - Common Stock | 4.33 USD | +7.71% | -6.28% | -1.37% | +147.43% | 201.73 M USD |